Skip to main content
. 2022 Jan 9;10(1):95. doi: 10.3390/vaccines10010095
FDA The United States Food and Drug Administration
GLMM Generalized linear mixed models
GRADE Grading of Recommendations, Assessment, Development, and Evaluation
IQR Interquartile range
MMF/MPA Mycophenolic acid
mTOR Mammalian target of rapamycin
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines
PROSPERO Prospective International Register of Systematic Reviews
RCT Randomized controlled trial
ROBINS-I Risk of Bias in Nonrandomized Studies of Intervention
SD Standard deviation